Advent International

国际冒险公司

, a leading global

，全球领先的

private equity investor

私募股权投资者

, signed a definitive agreement to invest $175 million via primary and secondary for a significant minority stake in Dublin-headquartered

，签署了一项最终协议，将通过主次交易投资1.75亿美元，以获取总部位于都柏林的公司的显著少数股权。

Felix Pharmaceuticals

菲利克斯制药公司

, a leading global generic animal pharma player, stated a company release.

，一家全球领先的仿制动物制药企业，在公司发布会上表示。

Felix

费利克斯

Pharma is a manufacturer of off-patent medicines for companion animals.

制药公司是一家为伴侣动物生产非专利药物的制造商。

Felix develops, manufactures and supplies to distributors and other branded generic players for private labelling, particularly in the US. With a portfolio of 14 approved products from

Felix 开发、制造并向分销商及其他自有品牌仿制药公司供应产品，用于私人标签，尤其是在美国。其拥有14种获批产品的组合。

USFDA

美国食品药品监督管理局

and many more under review and development, Felix has the widest portfolio of products in the industry.

还有许多产品正在审查和开发中，Felix拥有行业内最广泛的产品组合。

“Felix is well positioned to lead this generic space with its strong leadership, broad portfolio, and robust R&D and commercial capabilities. Its rapid growth and high customer satisfaction make it a differentiated platform, and we are excited to support Neeraj and the Felix team in scaling it into a global franchise,” said Shweta Jalan, Managing Partner at Advent..

“Felix凭借其强大的领导力、广泛的产品组合以及雄厚的研发和商业能力，非常适合引领这一通用领域。其快速增长和高客户满意度使其成为一个差异化的平台，我们非常期待支持Neeraj和Felix团队将其扩展为全球特许经营业务，”Advent的管理合伙人Shweta Jalan表示。

Felix was founded in 2015 by Neeraj Agrawal, Sir Jonathan Symonds and Dr Shumeet Banerji, ex-CEO of Booz-Allen. While the company achieved its first US FDA approval in 2020, marking a pivotal step in its expansion, it has quickly scaled to a 14 commercialised product portfolio and has several others in advanced stages of pipeline, it said.

Felix 由 Neeraj Agrawal、Sir Jonathan Symonds 和前博思艾伦首席执行官 Shumeet Banerji 博士于2015年创立。该公司表示，虽然其在2020年获得了首个美国FDA批准，标志着其扩展过程中的关键一步，但公司已经迅速扩展到拥有14个商业化产品组合，并且还有其他几个产品处于管线的高级阶段。

It has a USFDA approved oral solid facility dedicated for .

它拥有一个美国食品药品监督管理局（USFDA）批准的专用口服固体制剂设施。

animal health products

动物健康产品

and an injectable facility that is expected to be ready by Q3 2025.

预计到 2025 年第三季度将准备好一个可注射的设施。

Neeraj Agrawal, Co-Founder of Felix Pharma, said, “As we scale in a fast-evolving market, we were looking for a partner who brings not just capital, but also deep operating expertise and the right mindset and networks to help us grow faster and stronger.”

费利克斯制药联合创始人尼拉吉·阿格拉瓦尔表示：“在快速发展的市场中扩张时，我们希望寻找的合作伙伴不仅能够带来资金，还能提供深厚的运营专业知识、正确的思维模式以及有助于我们更快更强发展的网络。”

Live Events

现场活动

(You can now subscribe to our

（您现在可以订阅我们的

Economic Times WhatsApp channel

经济时报WhatsApp频道

)

)

(You can now subscribe to our

（你现在可以订阅我们的

Economic Times WhatsApp channel

经济时报 WhatsApp 频道

)

)